moderna stock price january 2020

Averaged Moderna stock price for month 137. The Moderna 52-week high.

Why Moderna Stock Fell 32 In December Nasdaq

2 Modernas stock opened at 1957.

. 1 2020 a year after the IPO and eight weeks before the first reported COVID death in the US the stock was up 5 from its initial offering price and Moderna still. Moderna Stock Price Forecast. The next day the companys shares began trading on the Nasdaq stock exchangeWas.

And if you held on until today with the stock. MRNA has rallied from around 104 per share at the end of 2020 to about 485 as of Monday an increase of over 45x. Overview Detailed Quote Charting Historical.

A nyone who invested 10000 in Moderna NASDAQ. Yet even more gains may be in store for Moderna investors in 2021. Shares of clinical-stage biotech Moderna MRNA -216 rose 155 in March according to data from SP Global Market Intelligence.

Find the latest Moderna Inc. The all-time high Moderna stock closing price was 48447 on August 09 2021. NAKD Stock Price Forecast.

The latest closing stock price for Moderna as of January 21 2022 is 16007. Moderna stock price january 2020 Tuesday April 5 2022 Edit. Moderna stock predictions for.

Price at the end 139 change for January. Moderna announced an IPO price of 23 per share on Dec. Moderna Inc NQ.

Averaged Moderna stock price for month 170. With the Omicron variant spreading. Maximum value 147 while minimum 131.

2 2020 Moderna stock closed at 1923. The Moderna 52-week low stock price is 11734 which is 343 below the current share price. What the MRNA Stock Price Tells Us.

The latest closing stock price for Moderna as of January 21 2022 is 16007. Was the stock a buy before 2020. And if you held on until today with the stock trading at around 170.

Counting the cash. This compares to the SP. With an abundance of fanfare Moderna went public in late 2018 and it was the largest biotech initial public offering IPO in history at the time.

400 PM EDT May 20 2022 Add to My Watchlist. Thats a much better performance than. If you had invested 1000 at that time you would own approximately 51 shares.

31 Modernas stock price is up 446 in. Are in the red today after closing at 21523 as of January 5 th 1959 EST. MRNA announced positive interim results from a phase 1 study of its COVID-19 vaccine candidate mRNA-1273 on May 18 2020.

Owing to a higher share count its market. In total Bancel sold more than 28 million. MRNA stock quote history news and other vital information to help you with your stock trading and investing.

Moderna stock NASDAQ. View daily weekly or monthly format back to when Moderna Inc. -498 Streaming Delayed Price Updated.

The forecast for beginning of January 132. The Top And Bottom 5 Stocks Of 2021 Moderna Executives Sell Stock As Coronavirus Vaccine Boosts. The biotech company plans to use the profits it earns from sales of mRNA-1273 to fund the development of.

102 rows Discover historical prices for MRNA stock on Yahoo Finance. Since then MRNA has rallied 734. Maximum value 418 while minimum 370.

In November 2020 I estimated that its Covid-19 vaccine now branded SpikeVax -- could add as much as 35 billion to Modernas revenues. Moderna stock rallied by over 10 on Wednesdays trading after the European Union agreed to buy 80 million doses of its Covid-19 vaccine with an option to buy up an.

Mrna Stock News Moderna Stock Price Today Analyst Opinions Markets Insider

If You Invested 1 000 In Moderna In January This Is How Much You D Have Now The Motley Fool

Moderna Biontech Lose Nearly 60 Billion In Value In Two Day Drop Business Standard News

The Millionaire Who Gave Moderna A Shot Wsj

Moderna Executives Sell Stock As Coronavirus Vaccine Boosts Company Shares The Washington Post

Moderna Says Omicron Vaccine Could Be Ready By Early 2022 Coronavirus Pandemic News Al Jazeera

Is It Too Late To Buy Moderna Stock The Motley Fool

Live News From January 21 Global Stocks Notch Worst Week Since 2020 Us And Russia Plan Further Ukraine Talks After Blinken Lavrov Meeting Boe Policymaker Cautions On Wage And Price Expectations Financial Times